Press releases

To stay up to date with our development, sign up for a subscription.


Exercise of the overallotment option


Pareto Securities has notified Sedana Medical AB (publ) (”Sedana Medical” or the ”Company”), that the overallotment option has been exercised in full.

Sedana Medical AB (publ) launches AnaConDa-S


Sedana Medical AB (publ) ("Sedana Medical" or "the Company") is launching AnaConDa-S, a new innovation and an enhancement of its predecessor AnaConDa, in which the ‘dead volume’ has been halved from 100 ml to 50 ml. Halving the dead volume increases…

Sedana Medical AB (publ) registers AnaConDa in South Korea


Sedana Medical AB’s (publ) (“Sedana Medical” or " the Company") product AnaConDa is approved by K-FDA in South Korea. South Korea is the first country in Asia to approve AnaConDa. The product will be launched in cooperation with the distributor DaeSe…

Christer Ahlberg new CEO of Sedana Medical AB (publ)


The Board of Directors of Sedana Medical AB (publ) ("Sedana Medical" or "the Company") has appointed Christer Ahlberg as new CEO for the Company and the group. Christer Ahlberg succeeds Mike Ryan, who will focus on board management inside and outside…